Etemadmoghadam et al [16] reported the mutual exclusivity of homologous recombination pathway dysfunction and CCNE1 amplification, which might explain the inadequate response to platinum therapy and thus the poor prognosis of CCNE1-overexpressing tumours. Here, CCNE1 is linked to neoplasm.